InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Huh Hoyoung. Director active across 2 companies, notably Akari Therapeutics Plc. In total, 13 reports have been recorded. Breakdown: 7 buys · 0 sell. Total volume traded: €1k. Activity tracked since 1 November 2022. The latest transaction was disclosed on 6 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Huh Hoyoung is a declarant linked to Peak Bio, Inc. and Akari Therapeutics Plc, where he is a Director. He has 13 filings in total. In the recent filings tracked, they cover the period from 2022-11-03 to 2025-03-10, with EUR 1,265 of buys and EUR 0 of sells, and the most common transaction nature is Acquisition.